Human Molecular Genetics, 2001, Vol. 10, No. 20 2301-2305
© 2001 Oxford University Press
Challenges in identifying genetic variation affecting susceptibility to type 2 diabetes: examples from studies of the calpain-10 gene
The University of Chicago, Department of Human Genetics, 507H CLSC, 920 East 58th Street, Chicago, IL 60637, USA
Type 2 diabetes is a classic example of a complex disorder. It is strongly familial, but clearly arises as a consequence of the actions and interactions of many genetic and non-genetic factors. Type 2 diabetes is a common disorder, affecting 16 million Americans. It has a major impact on public health expenditures with more than 1 in 10 health care dollars spent on treating diabetes and its complications. Although a variety of therapies can be useful in treatment of type 2 diabetes, we remain sufficiently ignorant of the genetic risk factors to believe that identifying them will lead to better understanding of the primary physiology of the disorder, as well as to more specific and effective therapies. Moreover, identification of genetic risk factors may improve our ability to characterize more specific non-genetic risk factors for this disease that could be the targets for cost-effective prevention strategies. This manuscript reviews the challenges we face in moving from the linkage mapping of susceptibility genes for type 2 diabetes toward the identification of the genetic variation that actually affects risk to this disorder. I illustrate many of the challenges in designing, conducting and interpreting these studies by reviewing recent research conducted on the calpain-10 gene, implicated in positional cloning studies as a candidate gene for type 2 diabetes.
+ Tel: +1 773 834 1001; Fax: +1 773 834 0505; Email: ncox@genetics.bsd.uchicago.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  J. N. ANDERSEN, P. G. JANSEN, S. M. ECHWALD, O. H. MORTENSEN, T. FUKADA, R. DEL VECCHIO, N. K. TONKS, and N. P. H. MOLLER A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage FASEB J, January 1, 2004; 18(1): 8 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. W. Mohrenweiser Genetic Variation and Exposure Related Risk Estimation: Will Toxicology Enter a New Era? DNA Repair and Cancer as a Paradigm Toxicol Pathol, January 1, 2004; 32(1_suppl): 136 - 145. [Abstract] [PDF]
|
|
|
|
 |
|
 J. E. Gerich Contributions of Insulin-Resistance and Insulin-Secretory Defects to the Pathogenesis of Type 2 Diabetes Mellitus Mayo Clin. Proc., April 1, 2003; 78(4): 447 - 456. [Abstract] [PDF]
|
|
|
|
 |
|
 D. J. Smith and A. J. Lusis The allelic structure of common disease Hum. Mol. Genet., October 1, 2002; 11(20): 2455 - 2461. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. McCarthy and P. Froguel Genetic approaches to the molecular understanding of type 2 diabetes Am J Physiol Endocrinol Metab, August 1, 2002; 283(2): E217 - E225. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Haddad, J. C. Evans, N. Gharani, C. Robertson, K. Rush, S. Wiltshire, T. M. Frayling, T. J. Wilkin, A. Demaine, A. Millward, et al. Variation within the Type 2 Diabetes Susceptibility Gene Calpain-10 and Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2606 - 2610. [Abstract] [Full Text] [PDF]
|
|